Welcome to our dedicated page for iCoreConnect news (Ticker: ICCT), a resource for investors and traders seeking the latest updates and insights on iCoreConnect stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect iCoreConnect's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of iCoreConnect's position in the market.
iCoreConnect (OTCQB: ICCT) has announced the acceptance of six SaaS products into the Missouri Dental Association's Perks Dentist Business Ally Program. The products include iCoreRx (e-Prescribing), iCoreExchange (HIPAA-compliant email), iCoreDental (Practice management), iCoreHuddle (Revenue optimizer), iCoreIT (Managed IT services), and iCoreCodeGenius (Cross-coding). This partnership is aimed at enhancing operational speed and business growth for dental practices, supported by positive feedback from the MDA's members.